A detailed history of Victory Capital Management Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Victory Capital Management Inc holds 136,282 shares of ALKS stock, worth $3.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
136,282
Previous 115,061 18.44%
Holding current value
$3.8 Million
Previous $2.77 Million 37.59%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$23.01 - $28.55 $488,295 - $605,859
21,221 Added 18.44%
136,282 $3.81 Million
Q2 2024

Aug 05, 2024

BUY
$23.21 - $27.24 $599,908 - $704,072
25,847 Added 28.97%
115,061 $2.77 Million
Q1 2024

May 03, 2024

BUY
$26.4 - $32.56 $329,894 - $406,869
12,496 Added 16.29%
89,214 $2.42 Million
Q4 2023

Feb 05, 2024

BUY
$23.37 - $28.68 $15,774 - $19,359
675 Added 0.89%
76,718 $2.13 Million
Q3 2023

Nov 06, 2023

BUY
$27.17 - $31.97 $13,068 - $15,377
481 Added 0.64%
76,043 $2.13 Million
Q2 2023

Jul 27, 2023

SELL
$28.34 - $33.63 $11,676 - $13,855
-412 Reduced 0.54%
75,562 $2.37 Million
Q1 2023

May 02, 2023

SELL
$25.31 - $29.02 $10,199 - $11,695
-403 Reduced 0.53%
75,974 $2.14 Million
Q4 2022

Feb 10, 2023

BUY
$21.94 - $26.24 $3,642 - $4,355
166 Added 0.22%
76,377 $2 Million
Q4 2022

Feb 09, 2023

BUY
$21.94 - $26.24 $92,630 - $110,785
4,222 Added 5.86%
76,211 $1.99 Million
Q3 2022

Nov 02, 2022

SELL
$22.0 - $31.87 $24.3 Million - $35.2 Million
-1,103,585 Reduced 93.88%
71,989 $1.61 Million
Q2 2022

Aug 01, 2022

BUY
$26.4 - $30.54 $28.8 Million - $33.3 Million
1,089,504 Added 1265.83%
1,175,574 $35 Million
Q1 2022

May 04, 2022

SELL
$23.07 - $27.99 $893,131 - $1.08 Million
-38,714 Reduced 31.02%
86,070 $2.48 Million
Q4 2021

Feb 07, 2022

SELL
$21.47 - $32.08 $787,283 - $1.18 Million
-36,669 Reduced 22.71%
124,784 $2.9 Million
Q3 2021

Nov 02, 2021

BUY
$23.37 - $32.13 $3.27 Million - $4.5 Million
139,962 Added 651.26%
161,453 $4.98 Million
Q2 2021

Aug 03, 2021

SELL
$18.78 - $25.15 $9,371 - $12,549
-499 Reduced 2.27%
21,491 $527,000
Q1 2021

May 04, 2021

SELL
$18.21 - $23.2 $12,237 - $15,590
-672 Reduced 2.97%
21,990 $411,000
Q4 2020

Feb 01, 2021

BUY
$15.39 - $22.1 $60,821 - $87,339
3,952 Added 21.12%
22,662 $452,000
Q3 2020

Nov 09, 2020

SELL
$16.16 - $20.66 $38,380 - $49,067
-2,375 Reduced 11.26%
18,710 $310,000
Q2 2020

Aug 07, 2020

BUY
$13.31 - $19.41 $22,773 - $33,210
1,711 Added 8.83%
21,085 $409,000
Q1 2020

May 04, 2020

SELL
$13.06 - $21.24 $36,698 - $59,684
-2,810 Reduced 12.67%
19,374 $279,000
Q4 2019

Feb 06, 2020

BUY
$17.29 - $21.74 $65,044 - $81,785
3,762 Added 20.42%
22,184 $453,000
Q4 2019

Feb 04, 2020

BUY
$17.29 - $21.74 $25,416 - $31,957
1,470 Added 8.67%
18,422 $321,000
Q3 2019

Nov 12, 2019

BUY
$19.51 - $24.28 $330,733 - $411,594
16,952 New
16,952 $331,000
Q1 2018

May 04, 2018

SELL
$53.61 - $67.26 $1.92 Million - $2.41 Million
-35,810 Closed
0 $0
Q4 2017

Feb 01, 2018

SELL
$47.69 - $55.39 $28.7 Million - $33.3 Million
-601,690 Reduced 94.38%
35,810 $1.96 Million
Q3 2017

Oct 27, 2017

SELL
$49.16 - $54.45 $27.5 Million - $30.5 Million
-559,912 Reduced 46.76%
637,500 $32.4 Million
Q2 2017

Aug 07, 2017

BUY
N/A
1,197,412
1,197,412 $69.4 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.58B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.